Irinotecan (CPT-11) and Mitomycin-C (MMC) as Second-Line Therapy in Advanced Gastric Cancer : A Phase II Study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106)
You can manage bookmarks using lists, please log in to your user account for this.
Media type:
E-Article
Title:
Irinotecan (CPT-11) and Mitomycin-C (MMC) as Second-Line Therapy in Advanced Gastric Cancer : A Phase II Study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106)
:
A Phase II Study of the Gruppo Oncologico dell' Italia Meridionale (prot. 2106)